Dysport (Ipsen Biopharmaceuticals, Inc.)


Welcome to the PulseAid listing for the Dysport drug offered from Ipsen Biopharmaceuticals, Inc.. This Acetylcholine Release Inhibitor [EPC],Acetylcholine Release Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Ipsen Biopharmaceuticals, Inc.
NON-PROPRIETARY NAME: Botulinum Toxin Type A
SUBSTANCE NAME: BOTULINUM TOXIN TYPE A
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Acetylcholine Release Inhibitor [EPC],Acetylcholine Release Inhibitors [MoA]
ROUTE: INTRAMUSCULAR
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2009-11-02
END MARKETING DATE: 0000-00-00


Dysport HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDysport from Ipsen Biopharmaceuticals, Inc.
LABELER NAME: Ipsen Biopharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 500(U/1)
START MARKETING DATE: 2009-11-02
END MARKETING DATE: 0000-00-00
PRODUCT ID: 15054-0500_f0cc4070-ca90-4f6f-8846-7f197926e4fc
PRODUCT NDC: 15054-0500
APPLICATION NUMBER: BLA125274

Other BOTULINUM TOXIN TYPE A Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Allergan, Inc.BOTOX
Galderma Laboratories, L.P.Dysport
Ipsen Biopharmaceuticals, Inc.Dysport
Merz North America, Inc.Xeomin
Merz Pharmaceuticals, LLCXeomin